Biogen Inc (NASDAQ: BIIB) is -38.67% lower on its value in year-to-date trading and has touched a low of $153.62 and a high of $268.30 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BIIB stock was last observed hovering at around $157.90 in the last trading session, with the day’s gains setting it 0.81%.
Currently trading at $158.71, the stock is -5.51% and -12.33% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.07 million and changing 0.51% at the moment leaves the stock -23.48% off its SMA200. BIIB registered -31.58% loss for a year compared to 6-month loss of -27.44%. The firm has a 50-day simple moving average (SMA 50) of $181.8416 and a 200-day simple moving average (SMA200) of $207.80815.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -12.65% gain in the last 1 month and extending the period to 3 months gives it a -21.93%, and is 0.49% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.83% over the week and 2.67% over the month.
Biogen Inc (BIIB) has around 7570 employees, a market worth around $23.13B and $9.23B in sales. Current P/E ratio is 14.34 and Fwd P/E is 9.47. Profit margin for the company is 17.50%. Distance from 52-week low is 3.31% and -40.84% from its 52-week high. The company has generated returns on investments over the last 12 months (7.60%).
with sales reaching $2.42B over the same period.The EPS is expected to grow by 11.46% this year, but quarterly earnings will post -1.99% year-over-year. Quarterly sales are estimated to grow 1.38% in year-over-year returns.
Biogen Inc (BIIB) Top Institutional Holders
1369.0 institutions hold shares in Biogen Inc (BIIB), with institutional investors hold 93.07% of the company’s shares. The shares outstanding are 144.90M, and float is at 144.68M with Short Float at 2.16%. Institutions hold 92.93% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 16.6 million shares valued at $3.85 billion. The investor’s holdings represent 11.4326% of the BIIB Shares outstanding. As of 2024-06-30, the second largest holder is PRIMECAP MANAGEMENT CO/CA/ with 16.34 million shares valued at $3.79 billion to account for 11.2523 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 14.54 million shares representing 10.0127% and valued at over $3.37 billion, while STATE STREET CORP holds 4.8871 of the shares totaling 7.1 million with a market value of $1.64 billion.
Biogen Inc (BIIB) Insider Activity
The most recent transaction is an insider sale by Singhal Priya, the company’s Head of Development. SEC filings show that Singhal Priya sold 431 shares of the company’s common stock on Sep 03 ’24 at a price of $204.22 per share for a total of $88019.0. Following the sale, the insider now owns 5316.0 shares.
Still, SEC filings show that on Apr 02 ’24, Singhal Priya (Head of Development) disposed off 93 shares at an average price of $213.09 for $19817.0. The insider now directly holds 4,886 shares of Biogen Inc (BIIB).
